This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of other and ill-defined digestive organs
C3_DIGESTIVE_ORGANS_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
299 |
4. Check minimum number of eventsNone |
299 |
5. Include endpointsNone |
299 |
6. Filter based on genotype QC (FinnGen only) |
281 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined digestive organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of other and ill-defined digestive organs, including Hilmo
- Malignant neoplasm of digestive organs
- Solid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 281 | 125 | 156 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 74.58 | 75.67 | 73.71 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 299
- Matched controls
- 2987
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z51.5
ICD-10 Finland
Palliative care
29.8
149.7
111
58
130
Kela drug reimbursment
Malignant tumour
+∞
147.4
129
*
H02AB02
ATC
dexamethasone; systemic
69.0
144.8
81
16
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
134.8
119
*
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
109.2
98
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
78.7
72
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.6
78.4
123
203
JN4BD
NOMESCO Finland
Extensive body CT
14.0
68.4
70
64
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
66.1
61
*
A04AA02
ATC
granisetron; systemic, transdermal
742.8
63.2
60
*
N02AA05
ATC
oxycodone; systemic
7.2
61.5
130
288
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
60.5
56
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
60.5
56
*
A04AA01
ATC
ondansetron; systemic, rectal
23.3
58.4
44
22
8000/3-C26.9
ICD-O-3
Neoplasm, malignant of gastrointestinal tract, NOS
+∞
58.2
54
*
L01BC06
ATC
capecitabine; oral
+∞
51.6
48
*
JN4AD
NOMESCO Finland
Body CT examination
10.4
50.8
63
75
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
42.7
40
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.0
38.5
39
34
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
54.0
35.8
42
9
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
35.1
33
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
153.7
27.1
28
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
26.4
25
*
B01AB10
ATC
tinzaparin; parenteral
6.0
24.8
48
92
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
24.3
23
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
29.6
24.1
32
12
R18
ICD-10 Finland
Ascites
26.3
24.0
33
14
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
23.2
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
23.2
22
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.6
22.9
106
399
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
47.2
21.8
26
6
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
21.1
20
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
21.1
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.5
20.6
36
62
WZC30
NOMESCO Finland
Teaching
4.1
18.4
58
166
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
17.9
17
*
8000/3-C26.0
ICD-O-3
Neoplasm, malignant of intestinal tract, NOS
+∞
17.9
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.3
17.9
52
140
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.1
17.2
24
32
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.8
17.0
29
23
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
67.3
16.9
19
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
16.8
16
*
8936/3-C26.9
ICD-O-3
Gastrointestinal stromal tumor of gastrointestinal tract, NOS
+∞
16.8
16
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
63.5
15.9
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
15.8
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
15.8
15
*
8010/3-C26.9
ICD-O-3
Carcinoma, NOS, of gastrointestinal tract, NOS
+∞
15.8
15
*
JAH00
NOMESCO Finland
Laparotomy
11.7
15.3
28
26
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
33.6
15.0
19
6
8140/3-C26.0
ICD-O-3
Adenocarcinoma, NOS, of intestinal tract, NOS
+∞
14.7
14
*
UJF32
NOMESCO Finland
Coloscopy
2.7
13.8
97
446
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
78.8
13.7
15
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
13.6
113
564
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
13.6
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
12.9
115
592
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
12.6
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
12.6
12
*
189
Kela drug reimbursment
Imatinib
+∞
12.6
12
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
135.3
12.5
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.2
12.3
21
17
JAH01
NOMESCO Finland
Laparoscopy
6.4
12.3
21
35
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
12.3
83
372
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
12.2
50
169
L02AE02
ATC
leuprorelin; implant, parenteral
67.6
11.7
13
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.5
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
11.5
11
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
11.5
11
*
B01AB05
ATC
enoxaparin; parenteral
2.4
10.9
105
552
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
10.7
43
143
L03AA02
ATC
filgrastim; parenteral
113.7
10.5
11
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
L01XE01
ATC
[U] imatinib
+∞
10.5
10
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
10.5
10
*
JFB00
NOMESCO Finland
Partial resection of small intestine
24.3
10.3
14
6
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
56.8
9.7
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
9.4
9
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
9.4
9
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
9.4
9
*
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
9.1
35
113
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
9.0
35
114
A06AH03
ATC
naloxegol; oral
51.5
8.7
10
*
H01CB03
ATC
lanreotide; parenteral
92.5
8.5
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
8.4
50
207
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
8480/3-C26.9
ICD-O-3
Mucinous adenocarcinoma of gastrointestinal tract, NOS
+∞
8.4
8
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
12.2
8.2
14
12
WF002
NOMESCO Finland
Radical radiotherapy
34.3
8.1
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
22.7
8.1
11
5
JN4CD
NOMESCO Finland
Very extensive body CT
9.8
7.9
15
16
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
7.8
23
62
HAB40
NOMESCO Finland
Wedge excision of mammary gland
46.2
7.7
9
*
JEA00
NOMESCO Finland
Appendectomy
4.4
7.6
19
45
JFF10
NOMESCO Finland
Loop enterostomy
82.0
7.4
8
*
ZX120
NOMESCO Finland
Intravenous
3.2
7.4
30
100
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.0
7.4
21
55
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.3
7
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
7
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
7.3
7
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
7.3
7
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
WX402
NOMESCO Finland
General anaesthesia
2.5
7.2
50
223
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
30.8
7.2
9
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.3
6.9
18
44
K83.1
ICD-10 Finland
Obstruction of bile duct
11.3
6.9
12
11
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.0
6.8
8
*
L02BG04
ATC
letrozole; oral
41.0
6.8
8
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
41.0
6.8
8
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.7
6.7
16
25
NK6AN
NOMESCO Finland
Total body bone isotope imaging
71.2
6.4
7
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.4
6.4
13
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.4
142
978
8240/3-C26.9
ICD-O-3
Neuroendocrine tumor, NOS, of gastrointestinal tract, NOS
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
176
Kela drug reimbursment
Regorafenib
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
6.3
6
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
6.3
6
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
6.3
6
*
C49.4
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of abdomen
+∞
6.3
6
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.5
6.1
41
180
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
175
114
35.57
220.37
3.6
1.4
207.01
2.90
ug/l
2.35
155
94
102
37
41.28
157.22
3.4
1.9
4854.11
17.66
u/ml
1.71
92
28
44
17
30.15
64.49
1.3
1.6
229.83
220.44
u/ml
0.01
44
17
220
1033
5.27
38.90
12.1
3.5
16.32
11.87
umol/l
1.64
213
962
38
11
39.28
30.46
1.7
1.5
21.90
12.97
ug/l
1.75
38
11
35
9
43.70
28.73
4.0
1.4
7.81
5.29
nmol/l
—
35
9
152
659
3.65
27.09
2.8
2.2
45.30
63.87
u/l
1.89
141
601
185
943
3.52
24.87
7.7
3.5
30.83
34.98
g/l
12.37
177
871
199
1108
3.37
22.21
15.3
5.4
5.42
4.40
e9/l
3.19
173
960
198
1142
3.17
19.97
11.6
18.0
1.33
1.43
inr
0.55
59
305
20
5
42.67
16.54
4.7
1.0
142.70
73.00
nmol/l
—
20
5
157
873
2.68
15.65
2.7
2.3
—
—
—
0
0
64
219
3.44
15.48
3.0
1.9
18.70
7.00
umol/l
1.73
64
190
101
452
2.86
15.39
2.3
1.9
—
—
—
0
0
53
169
3.59
14.23
2.1
1.9
0.17
0.20
g/l
1.76
47
145
230
1609
2.85
13.51
14.7
5.0
140.45
77.05
u/l
8.34
219
1460
176
1109
2.42
12.48
6.3
5.4
1.20
1.21
mmol/l
1.36
145
950
164
1005
2.40
12.34
5.7
4.9
1.20
1.21
mmol/l
2.08
158
886
52
181
3.26
12.09
2.8
2.0
39.15
31.76
u/l
0.75
46
144
18
20
9.49
9.16
1.6
1.3
130.67
71.90
pmol/l
0.84
18
20
187
1310
2.14
9.04
4.4
4.0
7.02
6.92
mmol/l
0.23
177
1220
20
43
4.91
8.95
1.4
1.3
—
—
—
0
0
106
608
2.15
8.60
4.3
2.6
49.61
35.26
u/l
1.49
100
577
18
41
4.60
7.52
1.6
1.4
—
—
—
0
0
16
22
7.61
7.28
1.2
1.6
41901.25
2690.31
e6/l
—
8
13
17
26
6.86
7.22
1.2
1.5
1200.30
1950.35
e6/l
—
10
17
62
309
2.27
6.98
2.0
2.4
2.12
2.28
g/l
1.36
56
282
67
350
2.18
6.71
2.0
2.3
11.47
12.81
umol/l
0.66
58
319
190
1431
1.90
6.46
4.9
4.7
9.00
1506.50
e6/l
—
5
32
58
290
2.24
6.45
2.2
2.4
22.52
22.31
%
0.02
45
250
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
77
3.30
6.31
3.1
2.5
0.41
0.38
u/ml
0.13
17
43
178
2162
0.56
5.40
4.0
5.4
2.57
2.61
mmol/l
0.19
150
1953
68
388
1.97
5.30
1.8
1.7
—
—
—
0
0
5
0
+∞
5.22
2.0
0.0
48.76
—
pmol/l
—
5
0
173
2098
0.58
4.87
3.7
4.8
4.44
4.48
mmol/l
0.15
147
1911
8
7
11.68
4.81
1.5
1.7
—
—
—
0
0
46
236
2.12
4.76
3.4
3.1
2.26
2.33
mmol/l
0.04
38
193
173
2075
0.60
4.29
3.6
4.8
1.39
1.45
mmol/l
0.90
150
1872
28
568
0.44
4.29
1.6
1.7
1.44
1.32
mmol/l
0.18
23
463
91
604
1.73
4.29
3.5
3.0
1.44
0.55
e6/l
1.95
66
456
90
600
1.71
4.16
2.4
2.1
2.93
3.12
mg/l
0.38
74
497
181
2138
0.61
4.07
3.7
4.9
6.23
6.12
mmol/l
0.38
148
1902
166
2001
0.62
4.07
3.3
4.3
1.35
1.26
mmol/l
0.88
141
1783
18
68
2.75
3.63
2.2
3.4
—
—
—
0
0
175
2050
0.65
3.33
5.9
6.6
42.57
41.28
mmol/mol
0.87
155
1870
31
158
2.07
3.28
1.5
1.5
—
—
—
0
0
47
277
1.82
3.27
1.8
1.7
—
—
—
0
0
108
797
1.55
3.20
3.7
3.1
—
—
—
0
0
47
282
1.79
3.09
3.4
5.7
1.87
1.36
mmol/l
0.36
39
221
9
23
4.00
2.79
1.6
1.2
—
—
—
0
0
54
347
1.68
2.79
2.9
2.9
2.91
3.06
e6/l
0.05
23
183
29
155
1.96
2.72
2.7
4.1
5.12
5.11
kpa
0.03
29
149
126
991
1.47
2.65
3.3
4.0
32.86
78.26
ng/l
0.77
98
743
44
275
1.70
2.52
1.9
1.7
—
—
—
0
0
27
145
1.95
2.50
1.4
1.5
—
—
—
0
0
13
52
2.57
2.38
1.5
1.3
—
—
—
0
0
13
52
2.57
2.38
1.5
1.3
—
—
—
0
0
152
1260
1.42
2.32
3.7
2.9
120.06
50.68
u/l
3.78
143
1153
26
143
1.89
2.26
2.8
4.2
2.28
2.14
mmol/l
0.06
21
101
75
559
1.45
2.01
3.5
2.5
5034.79
12034.13
umol/l
0.68
62
485
36
231
1.63
1.89
4.2
3.2
—
—
—
0
0
24
139
1.79
1.81
1.8
1.7
—
—
—
0
0
233
2136
1.41
1.66
27.8
14.0
46.75
25.02
mg/l
10.30
224
1666
51
371
1.45
1.55
2.9
2.7
2.00
1.26
e6/l
0.27
20
206
17
93
1.88
1.54
1.8
1.6
—
—
—
0
0
7
27
2.63
1.52
1.1
1.4
—
—
—
0
0
13
66
2.01
1.45
1.0
1.3
—
—
—
0
0
16
88
1.86
1.44
1.6
1.5
—
—
—
0
0
63
801
0.73
1.43
3.9
3.7
29.29
6.88
mg/mmol
0.74
38
512
5
17
2.97
1.36
1.6
1.5
82.00
82.35
umol/l
—
5
17
5
18
2.80
1.29
1.8
1.1
—
—
—
0
0
58
448
1.36
1.27
2.0
1.7
4.39
1.26
mg/l
2.70
53
351
20
125
1.64
1.20
1.2
2.4
1.82
1.19
%
1.04
20
125
0
33
0.00
1.17
0.0
1.7
—
—
—
0
0
0
34
0.00
1.16
0.0
1.2
—
249.16
—
0
15
5
20
2.52
1.15
2.4
1.2
—
—
—
0
0
5
20
2.52
1.15
2.4
1.2
—
—
—
0
0
25
170
1.51
1.08
3.5
5.9
25.44
24.45
mmol/l
0.52
25
161
19
121
1.61
1.08
1.2
2.4
0.99
0.63
%
1.47
19
121
87
1022
0.79
1.07
2.6
2.5
—
—
—
0
0
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
5
23
2.19
0.98
1.2
1.2
—
—
—
0
0
15
230
0.63
0.93
1.3
1.4
—
—
—
0
0
29
389
0.72
0.92
1.3
1.2
0.73
1.72
u/ml
—
9
105
6
29
2.09
0.89
2.2
1.1
—
—
—
0
0
6
29
2.09
0.89
2.2
1.1
—
—
—
0
0
42
528
0.76
0.87
3.7
4.3
1.02
1.02
kg/l
—
10
84
20
284
0.68
0.87
3.1
5.0
32.70
32.16
%
—
10
181
6
31
1.95
0.84
1.5
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
6
33
1.83
0.79
3.0
2.9
69.33
60.09
%
—
6
33
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
39
486
0.77
0.77
3.6
2.6
0.75
0.78
ug/l
0.08
28
333
186
1980
0.84
0.76
3.6
4.5
1.86
2.60
mu/l
0.62
165
1762
7
38
1.86
0.74
1.0
1.7
—
—
—
0
0
7
40
1.77
0.71
1.1
1.3
—
—
—
0
0
5
26
1.94
0.71
1.6
1.1
—
—
—
0
0
7
41
1.72
0.70
2.0
1.1
—
—
—
0
0
63
539
1.21
0.65
2.0
1.8
1135.57
1209.33
nmol/l
0.18
51
403
62
715
0.83
0.62
4.4
3.8
22.00
24.75
%
0.63
35
350
171
1609
1.14
0.52
3.7
4.1
25.31
13.02
mm/h
6.95
157
1442
96
868
1.15
0.52
2.7
2.6
348.85
127.85
ug/l
0.71
84
772
12
83
1.46
0.52
1.3
1.3
3.50
3.21
g/l
0.33
12
73
9
65
1.39
0.51
1.4
1.3
0.00
0.00
g/l
—
9
59
7
45
1.57
0.49
2.0
1.2
—
—
—
0
0
14
102
1.39
0.48
1.4
2.9
2.22
1.48
mmol/l
0.72
14
97
10
69
1.46
0.44
1.4
1.3
0.00
0.00
g/l
—
10
63
66
588
1.16
0.44
4.2
4.0
0.00
0.00
estimate
-0.00
27
163
6
94
0.63
0.43
1.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
3.90
—
0
10
0
15
0.00
0.41
0.0
1.1
—
189.13
—
0
15
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
12
89
1.36
0.38
1.3
1.3
8.62
7.92
g/l
0.72
12
79
12
89
1.36
0.38
1.3
1.3
4.41
3.81
g/l
0.43
12
79
12
89
1.36
0.38
1.3
1.3
—
—
—
0
0
17
134
1.28
0.37
1.9
2.9
24.67
25.12
mmol/l
0.20
17
128
5
79
0.63
0.36
1.0
1.0
—
—
—
0
0
10
74
1.36
0.32
1.4
1.3
34.69
36.84
g/l
—
10
64
10
74
1.36
0.32
1.4
1.3
0.62
0.49
g/l
—
10
65
232
2260
1.11
0.30
30.1
17.3
137.95
139.71
mmol/l
13.43
226
2181
28
322
0.86
0.29
10.3
7.6
—
—
—
0
0
154
1603
0.92
0.29
3.1
3.6
15.20
15.09
pmol/l
0.19
130
1418
85
908
0.91
0.28
4.2
3.9
2.82
2.12
ug/l
1.01
73
797
232
2265
1.10
0.27
30.4
17.4
4.00
4.01
mmol/l
0.43
226
2183
231
2257
1.10
0.25
17.9
8.8
32.09
24.83
u/l
2.60
222
2143
5
40
1.25
0.22
1.0
1.2
—
16.84
—
0
5
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
273.83
—
0
6
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
1.06
—
0
8
0
13
0.00
0.21
0.0
3.4
—
—
—
0
0
193
1975
0.93
0.20
29.0
13.0
74.78
72.43
ml/min/173m2
0.67
174
1578
52
559
0.91
0.20
1.9
1.8
528.99
430.56
pmol/l
0.51
38
453
6
52
1.16
0.19
1.0
2.6
101.17
105.06
mmol/l
—
6
52
19
169
1.13
0.15
1.6
1.7
1.50
1.67
%
0.51
14
143
89
857
1.05
0.13
2.7
3.2
1751.88
1812.07
ng/l
0.05
78
733
83
856
0.96
0.10
4.0
4.2
—
—
—
0
0
12
134
0.89
0.09
4.7
2.9
0.44
0.24
e6/l
0.19
12
128
107
1093
0.97
0.08
3.7
4.0
0.00
0.02
estimate
0.50
30
166
11
99
1.11
0.06
1.4
2.1
428.36
747.36
ug/l
0.27
11
92
233
2344
0.97
0.05
37.3
20.3
4.12
4.46
e12/l
17.11
225
2250
233
2344
0.97
0.05
37.4
20.2
36.77
39.81
%
10.67
216
2151
233
2343
0.97
0.05
37.3
20.3
273.51
240.86
e9/l
5.68
224
2265
27
258
1.05
0.04
1.7
2.5
3.06
7.34
ug/l
2.36
19
223
106
1075
0.98
0.04
3.7
4.0
0.00
0.01
estimate
0.50
32
189
65
635
1.03
0.04
1.5
1.6
20.82
20.92
nmol/l
0.02
54
530
17
177
0.96
0.01
1.2
1.3
—
—
—
0
0
107
1077
0.99
0.01
4.9
5.6
0.00
0.00
estimate
-0.00
32
166
16
166
0.96
0.01
5.4
2.2
57.60
55.19
ml/min/173m2
—
5
62
103
1026
1.00
0.00
1.9
2.1
93.64
91.74
pmol/l
0.13
55
512
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.23
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1646.00
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
5
51
0.98
-0.00
1.4
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
88
875
1.01
-0.00
2.1
2.3
73.23
78.34
nmol/l
0.74
73
755
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.1
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_DIGESTIVE_ORGANS_NAS – Malignant neoplasm of other and ill-defined digestive organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).